Participations à des congrès et colloques internationaux (33)
28.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new floating levodopa sustained-release dosage form. Poster présenté à la conférence 34th Annual meeting & Exposition of the Controlled Release Society (Long Beach USA).
29.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new multiple-unit sustained-release floating systems. Paper session presented at Journée des sciences pharmaceutiques belges (11 octobre 2007: Spa, Belgique).
30.
Goole, J., Hamdani, J., Vanderbist, F., & Amighi, K. (2006). In vitro and in vivo evaluation in healthy volunteers of a new sustained-release floating dosage form. Poster présenté à la conférence 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
31.
Goole, J., Hamdani, J., Vanderbist, F., & Amighi, K. (2006). In vitro and in vivo evaluation in healthy volunteers of riboflavin sustained-release floating minitablets. 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology Abstract session presented at 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology(Geneva)
32.
Goole, J., Vanderbist, F., & Amighi, K. (2006). Development of new floating levodopa sustained-release minitablets. Poster présenté à la conférence Journée de l’Ecole Doctorale.
33.
Goole, J. (2006). Nouvelles tendances en Pharmacie Galénique. Paper session presented at Coopération interuniversitaire ULB-UMH (16/12/2006: Mons, Belgique).
Brevets (7)
1.
Arrighi, A., Marquette, S., Denis, L., Peerboom, C., Goole, J., & Amighi, K. (2019). Dry microparticles composition.
2.
Nober, C., Manini, G., & Goole, J. (2019). 3D printing compositions for modified-release pharmaceutical applications.
3.
Ronchi, F., Goole, J., Amighi, K., Guillaume, G., & Stephenne, V. S. (2015). Multilayered pharmaceutically active compound-releasing microparticles in liquid dosage form.
4.
Goole, J., Deleers, M., Fanara, D., & Amighi, K. (2015). Pharmaceutical Formulation.
5.
Reeff, J., Amighi, K., De Vriese, C., & Goole, J. (2012). Sustained-release formulations useful in the treatment of diseases.
6.
Amighi, K., Reeff, J., Goole, J., & De Vriese, C. (2012). Formulations useful in the treatment of osteoarticular diseases.